Results 11 to 20 of about 2,358 (151)

Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease). [PDF]

open access: yesPLoS ONE, 2016
The neuronal ceroid lipofuscinoses are a group of lysosomal storage disorders that comprise the most common, genetically heterogeneous, fatal neurodegenerative disorders of children.
Kim Wager   +5 more
doaj   +9 more sources

Recognizing differentiating clinical signs of CLN3 disease (Batten disease) at presentation. [PDF]

open access: yesActa Ophthalmol, 2021
AbstractPurposeTo help differentiate CLN3 (Batten) disease, a devastating childhood metabolic disorder, from the similarly presenting early‐onset Stargardt disease (STGD1). Early clinical identification of children with CLN3 disease is essential for adequate referral, counselling and rehabilitation.MethodsMedical chart review of 38 children who were ...
Kuper WFE   +7 more
europepmc   +6 more sources

Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease [PDF]

open access: yesScientific Reports, 2021
Juvenile CLN3 disease is a recessively inherited paediatric neurodegenerative disorder, with most patients homozygous for a 1-kb intragenic deletion in CLN3. The btn1 gene is the Schizosaccharomyces pombe orthologue of CLN3.
Christopher J. Minnis   +6 more
doaj   +2 more sources

Recognition and epileptology of protracted CLN3 disease. [PDF]

open access: yesEpilepsia, 2023
AbstractObjectiveThis study was undertaken to analyze phenotypic features of a cohort of patients with protracted CLN3 disease to improve recognition of the disorder.MethodsWe analyzed phenotypic data of 10 patients from six families with protracted CLN3 disease.
Cameron JM   +10 more
europepmc   +4 more sources

Modeling CLN3 Batten disease in astrocytes reveals alterations in mitochondria homeostasis, fatty acid metabolism and oxidative stress response [PDF]

open access: yesJournal of Biomedical Science
Background CLN3 Batten disease is a severe pediatric neurodegenerative disorder caused by mutations in the CLN3 gene, most commonly a 1 kb deletion encompassing exons 7 and 8.
Mingyi Yang   +12 more
doaj   +2 more sources

Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN) [PDF]

open access: yesJournal of Neurodevelopmental Disorders
Background We interrogated auditory sensory memory capabilities in individuals with CLN3 disease (juvenile neuronal ceroid lipofuscinosis), specifically for the feature of “duration” processing.
Tufikameni Brima   +9 more
doaj   +2 more sources

Reversible synaptic deficits in early-stage batten disease [PDF]

open access: yesJournal of Translational Medicine
Background Juvenile neuronal ceroid lipofuscinosis (JNCL, Batten Disease) is a childhood-onset, neurodegenerative, lysosomal storage disorder caused by mutations in the lysosomal gene CLN3. Progressive cognitive decline is characteristic clinical feature,
Masood Ahmad Wani   +4 more
doaj   +2 more sources

Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease. [PDF]

open access: yesEBioMedicine, 2023
Chen J   +12 more
europepmc   +2 more sources

A diagnostic confidence scheme for CLN3 disease. [PDF]

open access: yesJ Inherit Metab Dis, 2021
AbstractOver the past 20 years, diagnostic testing for genetic diseases has evolved, leading to variable diagnostic certainty for individuals included in long‐term natural history studies. Using genotype and phenotype data from an ongoing natural history study of CLN3 disease, we developed a hierarchical diagnostic confidence scheme with three major ...
Masten MC   +8 more
europepmc   +3 more sources

Brain proton MR spectroscopy measurements in CLN3 disease. [PDF]

open access: yesMol Genet Metab, 2023
CLN3 is an autosomal recessive lysosomal disorder with intracellular accumulation of ceroid-lipofuscins. CLN3 classically has onset around 4-6 years of age involving vision loss, followed by developmental regression and seizures. Symptoms are progressive and result in premature death.
Dang Do AN   +5 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy